SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (244)10/12/2001 12:48:02 PM
From: Icebrg   of 1022
 
>>Genmab current price about DKr129. With just about 8 DKr to the $, that's about $16, with around $9 per share in cash. FWIW.>>

With 22 million shares that gives a market cap of around 352 mUSD. Of which - as far as I know - Medarex owns 45 % corresponding to abt. 160 mUSD. Which unfortunately is just a little more than 2 USD per Medarex share. Anyhow - better than nothing.

Ice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News